Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Formulations comprising human anti-RANKL monoclonal antibodies, and methods of using the same

Formulations comprising human anti-RANKL monoclonal antibodies, and methods of using the same

US Patent 11192952 · Granted Dec 7, 2021

Estimated economic value: $140,935,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods, systems, compositions, kits, apparatus and computer-readable media for 2025
Excipients to reduce the viscosity of antibody formulations and formulation comp2025
Methods of treatment of arthritis and/or psoriasis with pharmaceutical formulati2025
Methods for partner agnostic gene fusion detection2024
N-acetylated and non-acetylated dipeptides containing arginine to reduce the vis2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations comprising anti-RANKL antibodies and an aromatic ami2024
Pharmaceutical formulations and methods of making the same2022